His discovery of the protein fragment GLP-1 was crucial in the development of Ozempic, Wegovy and other blockbuster obesity ...

Seventeen GOP lawmakers rebuffed opposition from House leadership Thursday and voted to extend enhanced Obamacare subsidies for three years.

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

The opening days of 2026 have seen a clutch of UK retailers roll out products with an eye on the rising number of people ...

The global equine artificial insemination (AI) market is on a robust trajectory, projected to expand from USD 686.7 million ...

The Trump administration introduced Tuesday a new drug pricing model that seeks to allow Medicare Part D plans and state Medicaid agencies to cover GLP-1s, potentially expanding coverage for the ...

Dec 23 (Reuters) - The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D ...

Weight-loss pills that harness the same mechanism as the wildly popular drugs Wegovy and Ozempic are coming to the U.S. On Monday Novo Nordisk announced that the U.S. Food and Drug Administration ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Ironwood Pharmaceuticals Inc ...

ITHACA, NY. — The impact of GLP-1 medications on consumer food spending is meaningful, according to new research published by Cornell University. Within six months of taking the medications, ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...